What is Transferrin?
Transferrin is a glycoprotein produced by the liver and the principal carrier of iron (Fe³⁺) in plasma. Each transferrin molecule can bind two iron ions; the normal serum concentration in adults is typically 2.0–3.6 g/L. Via total iron-binding capacity (TIBC) — the maximum amount of iron that all the transferrin in the blood could bind — transferrin is measurable indirectly: TIBC (µmol/L) = 25.1 × transferrin (g/L). The half-life of transferrin is roughly 8–10 days, meaning it responds more slowly than ferritin but earlier than haemoglobin. Transferrin synthesis is inversely regulated by iron stores via hepcidin: with iron deficiency, synthesis rises in the liver (the body creates more transport capacity to capture the scarce iron more efficiently), while with iron excess production falls. Transferrin is also a negative acute-phase protein: with inflammation, infection, and tissue damage, production falls as part of the liver's response to inflammatory cytokines (IL-6, IL-1β), just as albumin falls with chronic disease. This means that with simultaneous iron-deficiency anaemia and inflammation, transferrin may not show the expected rise — complicating interpretation. Other causes of low transferrin include liver disease (reduced protein production), nephrotic syndrome (protein loss via urine), malnutrition, and pregnancy (fall from haemodilution).
Why is Transferrin relevant?
Transferrin is a key marker in the iron panel because, in combination with ferritin and transferrin saturation, it helps distinguish iron-deficiency anaemia from anaemia of chronic disease (ACD) — two forms of anaemia that look clinically similar but require different treatment. In iron-deficiency anaemia, transferrin is elevated (more transport capacity), ferritin is low, and transferrin saturation is low — all three pointing the same way. In ACD, ferritin is normal or elevated (as an acute-phase protein) but transferrin is normal to low, making the diagnosis less straightforward. Transferrin is also a measure of visceral protein status and has historically been used as a nutritional marker: a transferrin < 2.0 g/L in someone without an inflammatory context can point to malnutrition or insufficient protein intake. In patients recovering from malnutrition, illness, or surgery, transferrin tracks nutritional status well — with more precision than albumin (half-life 20 days) but more slowly than pre-albumin (half-life 2 days). In haemochromatosis and other iron-overload conditions, transferrin is low or normal while transferrin saturation is markedly elevated (> 45–55%) — a pattern that helps with initial screening, though HFE genotyping is the diagnostic standard.
Transferrin high or low — what it means
Always read transferrin alongside ferritin, serum iron, transferrin saturation, and — crucially — CRP. CRP is the key to correct interpretation: with elevated CRP (> 5–10 mg/L), ferritin as an acute-phase protein is falsely high and transferrin as a negative acute-phase protein is falsely low. With active inflammation, true iron deficiency can be masked by a 'normal' ferritin that is actually higher than iron stores justify — and a transferrin that is lower than expected for pure iron deficiency. The classic patterns in the iron panel: (1) iron-deficiency anaemia: transferrin high, ferritin low (< 30 µg/L), saturation low (< 20%), MCV low; (2) ACD: transferrin normal to low, ferritin normal to high, saturation low to normal, CRP elevated; (3) mixed (iron deficiency + ACD): ferritin low-normal (< 100 µg/L with elevated CRP is already suggestive of iron deficiency), transferrin low, saturation low, CRP elevated — this pattern requires clinical judgement. Timing considerations: transferrin does not vary substantially throughout the day (unlike serum iron) and does not require a fasting sample. In pregnancy transferrin rises physiologically; with oral contraceptives transferrin is also elevated (oestrogen effect). Factor these in during interpretation.
Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.
Read about our scientific approach →